azomycin has been researched along with chitosan in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Ahirwar, M; Gupta, Y; Jain, A; Jain, SK | 1 |
Lamas, MC; Leonardi, D; Olivieri, AC; Salomón, CJ | 1 |
García, MC; Jimenez-Kairuz, A; Manzo, RH | 1 |
Barrera, MG; Lamas, MC; Leonardi, D; Salomón, CJ; Tejada, G | 1 |
An, Y; Chen, D; Ding, Y; He, C; Hu, C; Liu, D; Liu, P; Tang, Q; Wang, X; Yang, R; Yu, W; Zhang, Z | 1 |
5 other study(ies) available for azomycin and chitosan
Article | Year |
---|---|
Design and development of hydrogel beads for targeted drug delivery to the colon.
Topics: Animals; Chitosan; Colon; Drug Delivery Systems; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogen-Ion Concentration; Nitroimidazoles; Polymethacrylic Acids; Rats; Solubility | 2007 |
Development of novel formulations for Chagas' disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks.
Topics: Administration, Oral; Chagas Disease; Chitosan; Drug Carriers; Drug Compounding; Drug Design; Humans; Microscopy, Electron, Scanning; Molecular Structure; Neural Networks, Computer; Nitroimidazoles; Particle Size; Solubility; Surface Properties; Trypanocidal Agents | 2009 |
Polysaccharides-based multiparticulated interpolyelectrolyte complexes for controlled benznidazole release.
Topics: Adhesiveness; Administration, Oral; Alginates; Capsules; Chagas Disease; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; Gelatin; Glucuronic Acid; Hexuronic Acids; Kinetics; Models, Chemical; Nitroimidazoles; Polyelectrolytes; Solubility; Solvents; Technology, Pharmaceutical; Trypanocidal Agents | 2018 |
A Novel Prototype Device for Microencapsulation of Benznidazole: In Vitro/In Vivo Studies.
Topics: Animals; Chitosan; Drug Compounding; Drug Liberation; Nitroimidazoles; Rats; Rats, Wistar | 2020 |
Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer.
Topics: Animals; Antineoplastic Agents; Chitosan; Female; Humans; Hyaluronan Receptors; Hyaluronic Acid; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Nitroimidazoles; Oligosaccharides; Optical Imaging; Phosphoramide Mustards; Photochemotherapy; Photosensitizing Agents; Prodrugs; Triple Negative Breast Neoplasms | 2021 |